|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001.PubMed/NCBI
|
|
3
|
Saslow D, Solomon D, Lawson HW, et al:
American Cancer Society, American Society for Colposcopy and
Cervical Pathology, and American Society for Clinical Pathology
screening guidelines for the prevention and early detection of
cervical cancer. Am J Clin Pathol. 137:516–542. 2012. View Article : Google Scholar
|
|
4
|
Farh KK, Grimson A, Jan C, et al: The
widespread impact of mammalian MicroRNAs on mRNA repression and
evolution. Science. 310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marzi MJ, Puggioni EM, Dall’Olio V, et al:
Differentiation-associated microRNAs antagonize the Rb-E2F pathway
to restrict proliferation. J Cell Biol. 199:77–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kane NM, Howard L, Descamps B, et al: Role
of microRNAs 99b, 181a, and 181b in the differentiation of human
embryonic stem cells to vascular endothelial cells. Stem Cells.
30:643–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu XC, Dong QZ, Zhang XF, et al:
microRNA-29a suppresses cell proliferation by targeting SPARC in
hepatocellular carcinoma. Int J Mol Med. 30:1321–1326.
2012.PubMed/NCBI
|
|
9
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JW, Choi CH, Choi JJ, et al: Altered
MicroRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Tang S, Le SY, et al: Aberrant
expression of oncogenic and tumor-suppressive microRNAs in cervical
cancer is required for cancer cell growth. PLoS One. 3:e25572008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pereira PM, Marques JP, Soares AR, Carreto
L and Santos MA: MicroRNA expression variability in human cervical
tissues. PLoS One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gocze K, Gombos K, Juhasz K, et al: Unique
microRNA expression profiles in cervical cancer. Anticancer Res.
33:2561–2567. 2013.PubMed/NCBI
|
|
14
|
Hirata H, Ueno K, Shahryari V, et al:
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder
cancer. PLoS One. 7:e510562012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie H, Zhao Y, Caramuta S, Larsson C and
Lui WO: miR-205 expression promotes cell proliferation and
migration of human cervical cancer cells. PLoS One. 7:e469902012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Wang HK, McCoy JP, et al:
Oncogenic HPV infection interrupts the expression of
tumor-suppressive miR-34a through viral oncoprotein E6. RNA.
15:637–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang F, Liu M, Li X and Tang H: MiR-214
reduces cell survival and enhances cisplatin-induced cytotoxicity
via down-regulation of Bcl2l2 in cervical cancer cells. Febs Lett.
587:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen Y, Wang P, Li Y, et al: miR-375 is
upregulated in acquired paclitaxel resistance in cervical cancer.
Br J Cancer. 109:92–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong J, Cheng M and Sun H: Function of
inducible nitric oxide synthase in the regulation of cervical
cancer cell proliferation and the expression of vascular
endothelial growth factor. Mol Med Rep. 9:583–589. 2014.PubMed/NCBI
|
|
20
|
Fiordalisi JJ, Keller PJ and Cox AD: PRL
tyrosine phosphatases regulate rho family GTPases to promote
invasion and motility. Cancer Res. 66:3153–3161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bai Y, Luo Y, Liu S, et al: PRL-1 protein
promotes ERK1/2 and RhoA protein activation through a non-canonical
interaction with the Src homology 3 domain of p115 Rho
GTPase-activating protein. J Biol Chem. 286:42316–42324. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen HC, Chen GH, Chen YH, et al: MicroRNA
deregulation and pathway alterations in nasopharyngeal carcinoma.
Br J Cancer. 100:1002–1011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu J, He ML, Wang L, et al: MiR-26a
inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma
through repression of EZH2. Cancer Res. 71:225–233. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang X, Liang L, Zhang XF, et al:
MicroRNA-26a suppresses tumor growth and metastasis of human
hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Hepatology. 58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang B, Liu XX, He JR, et al:
Pathologically decreased miR-26a antagonizes apoptosis and
facilitates carcinogenesis by targeting MTDH and EZH2 in breast
cancer. Carcinogenesis. 32:2–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huse JT, Brennan C, Hambardzumyan D, et
al: The PTEN-regulating microRNA miR-26a is amplified in high-grade
glioma and facilitates gliomagenesis in vivo. Genes Dev.
23:1327–1337. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Han C and Wu T: MicroRNA-26a
promotes cholangiocarcinoma growth by activating beta-catenin.
Gastroenterology. 143:246–256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu B, Wu X, Liu B, et al: MiR-26a
enhances metastasis potential of lung cancer cells via AKT pathway
by targeting PTEN. Biochim Biophys Acta. 1822:1692–1704. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kota J, Chivukula RR, O’Donnell KA, et al:
Therapeutic microRNA delivery suppresses tumorigenesis in a murine
liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu JW, Chang JG, Yeh KT, et al: Increased
expression of PRL-1 protein correlates with shortened patient
survival in human hepatocellular carcinoma. Clin Transl Oncol.
14:287–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Achiwa H and Lazo JS: PRL-1 tyrosine
phosphatase regulates c-Src levels, adherence, and invasion in
human lung cancer cells. Cancer Res. 67:643–650. 2007. View Article : Google Scholar : PubMed/NCBI
|
